We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TNXP market cap is 37.02M. The company's latest EPS is USD -0.6242 and P/E is -0.32.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 3.99M | 3.78M | 2.48M | 2.21M |
| Operating Income | -29M | -28.15M | -27.33M | -21.35M | -77.32M |
| Net Income | -28.36M | -27.98M | -27.32M | -14.94M | -78.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7.77M |
| Operating Income | -28.83M | -50.51M | -92.31M | -112.09M | -118.38M |
| Net Income | -31.09M | -52.17M | -92.29M | -116.88M | -116.66M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 159.74M | 139.28M | 154.46M | 135.34M | 70.31M |
| Total Liabilities | 19.27M | 18.45M | 48.93M | 27.2M | 28.2M |
| Total Equity | 140.46M | 120.83M | 105.53M | 108.14M | 42.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.56M | 98.18M | 240.9M | 225.69M | 154.46M |
| Total Liabilities | 5.14M | 10.54M | 22.18M | 18.51M | 48.93M |
| Total Equity | 9.42M | 87.65M | 218.72M | 207.18M | 105.53M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -56.28M | -79.66M | -102M | -17.58M | -27.49M |
| Investing | -27.82M | -28.64M | -29.07M | -108k | -108k |
| Financing | -10.47M | -4.2M | 36.52M | -212k | 6.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.68M | -48.57M | -75.56M | -98.05M | -102M |
| Investing | -17k | -8.56M | -35.31M | -48.15M | -29.07M |
| Financing | 12.92M | 123.11M | 212.49M | 87.84M | 36.52M |
| Market Cap | 37.02M |
| Price to Earnings Ratio | -0.32 |
| Price to Sales Ratio | 4.81 |
| Price to Cash Ratio | 1.5 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 186.89M |
| Average Volume (1 week) | 156.27M |
| Average Volume (1 Month) | 48.15M |
| 52 Week Change | -98.75% |
| 52 Week High | 22.1376 |
| 52 Week Low | 0.118 |
| Spread (Intraday) | 0 (1.26%) |
| Company Name | Tonix Pharmaceuticals Holding Corporation |
| Address |
769 basque way carson city, nevada 89706 |
| Website | https://www.tonixpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
